Full-Time

Manager Biostatistics

Confirmed live in the last 24 hours

Pfizer

Pfizer

10,001+ employees

Develops and manufactures vaccines and medicines

Biotechnology
Healthcare

Compensation Overview

$99.9k - $166.5kAnnually

+ Bonus

Mid

New City, NY, USA

Relocation support available.

Category
Computational Biology
Biology Lab & Research
Biology & Biotech
Required Skills
R
Requirements
  • Master's degree in Statistics/Biostatistics
  • At least 3+ years of pharmaceutical experience
  • Some pre-clinical and non-clinical experience is required
  • Must have technical competence, including statistical computing
  • Sound understanding of design of experiments, assay development, and statistical applications for preclinical research
  • Knowledge of drug development regulations pertinent to statistical analysis
  • Experience collaborating 1:1 with scientists and/or non-statisticians
  • Statistical knowledge through coursework and/or demonstrated statistical application in general linear models, mixed models, non-linear models, experimental design, variance components, and quality control
  • Computational skills in R and SAS
  • PhD in Statistics/Biostatistics or relevant discipline (Nice-to-Have)
  • Assay validation experience, particularly clinical assays, is highly desired (Nice-to-Have)
  • Vaccine development experience is highly desired (Nice-to-Have)
  • Strong communication skills and the ability to work collaboratively with research scientists are essential (Nice-to-Have)
  • Demonstrated ability to create computational tools for data visualization (Nice-to-Have)
  • Demonstrated ability to work effectively as a part of a team. Strong communication skills and the ability to write technical reports (Nice-to-Have)
Responsibilities
  • Collaborate with vaccine assay specialists to support vaccine clinical and diagnostic assay development, qualification, and validation
  • Collaborate with vaccine preclinical scientists to support vaccine preclinical and nonclinical development
  • Ensure statistical rigor and good scientific practices are followed, excellent statistical methods utilized, and documented in protocols, analysis plans and manuscripts
  • Provide statistical expertise to regulatory submissions and ensure quality and appropriateness of submission deliverables
  • Bring innovative statistical thinking and methods to maximize the value of aggregate clinical and preclinical data in support of scientific and vaccine development strategies
  • Serve as a core member of scientific teams responsible for determining strategy and delivering results in a timely and high quality manner
  • Where possible, standardize processes and methodologies, may include developing statistical tools to aid scientists in standardized analyses
  • Use statistical expertise to prepare both internal and external reports, presentations and manuscripts, with the aim to improve the quality of internal decision making and increase our influence on the external environment

Pfizer is a biopharmaceutical company that focuses on creating and producing healthcare products, including medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold to various clients such as governments, healthcare providers, and patients around the world. Pfizer's products include vaccines, oncology treatments, and other specialized medicines. A notable achievement is its partnership with BioNTech to develop a vaccine for COVID-19, which has played a significant role in addressing the pandemic. Pfizer aims to improve public health by ensuring access to vaccines, especially for underserved populations, and continues to grow its product offerings with new approvals and treatments.

Company Stage

IPO

Total Funding

$3.8B

Headquarters

New York City, New York

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • Pfizer's significant investments in companies like CellCentric and Caribou Biosciences indicate a strong focus on expanding its oncology and cell therapy capabilities.
  • The company's proactive approach in securing investments and partnerships positions it well for future growth and innovation in the biopharmaceutical sector.
  • Pfizer's involvement in funding rounds for promising biotech firms suggests potential for lucrative returns and strategic advancements in healthcare solutions.

What critics are saying

  • The slowdown in demand for COVID-19 vaccines could impact Pfizer's revenue and market perception.
  • Activist investor involvement, such as Starboard Value's $1 billion stake, may lead to pressure for strategic changes that could affect company stability.

What makes Pfizer unique

  • Pfizer's strategic partnerships and investments in innovative biotech companies like Promise Bio and Enara Bio highlight its commitment to cutting-edge research and development.
  • The company's collaboration with BioNTech for the COVID-19 vaccine showcases its ability to rapidly respond to global health crises, setting it apart from many competitors.
  • Pfizer's diverse portfolio, including oncology and specialized medicines, ensures a broad market reach beyond just vaccines.

Help us improve and share your feedback! Did you find this helpful?